PR Newswire
- Credit Suisse 31st Annual Healthcare Conference 2022: November 8th , 8:35amPT / 11:35amET , in Rancho Palos Verdes, CA
- 13th Annual Jefferies Global Healthcare Conference 2022: November 16th , 8:35amGMT , in London, England
SAN RAFAEL, Calif. , Nov. 3, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. ( NASDAQ : BMRN ) today announced that management will present at two upcoming investor conferences. To access the live webcasts , please visit: https://investors.biomarin.com/ . An archived version of the presentations will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com . Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | 415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.